Original article
Overall survival in multiple myeloma in Brazil: A cohort of 16 years
Deborah Marta do Santos Oliveiraa,1, Isabela Cristina Menezes de Freitasa,b, Wallace Mateus Prataa,c, Isabella Zuppo Lapera,b, Pâmela Santos Azevedoa,b, Adriano de Paula Sabinoa, Marisa Yurico Itonagad, Carmino Antonio de Souzae, Mariângela Leal Cherchigliaf, Juliana Alvares Teodoroa,b, Francisco de Assis Acurcioa,b, Augusto Afonso Guerra Juniora,b,1,
Autor para correspondência
augustoguerrajr@ufmg.br
Corresponding author at: Collaborating Centre for Technology Assessment in Health and Excellence (CCATES), Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Corresponding author at: Collaborating Centre for Technology Assessment in Health and Excellence (CCATES), Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
a Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
b Collaborating Centre for Technology Assessment in Health and Excellence (CCATES), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
c Research and Development Directorate of the Ezequiel Dias Foundation, Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
d Health Consultant Specialized in Oncology, São Paulo, Brazil
e Hematology and Hemotherapy Center, University of Campinas, São Paulo, Brazil
f Department of Preventive and Social Medicine at the Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
